Log In
Print this Print this

GLP-2-XTEN (NB1002)

  Manage Alerts
Collapse Summary General Information
Company Amunix Operating Inc.
DescriptionGlucagon-like peptide-2 receptor (GLP-2R) agonist
Molecular Target Glucagon-like peptide-2 receptor (GLP-2R)
Mechanism of ActionGlucagon-like peptide-2 (GLP-2) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationShort bowel syndrome
Indication DetailsTreat short bowel syndrome (SBS)
Regulatory Designation
PartnerNaia Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today